Organic Chemistry TRIZ Cases

Dinitrate esters of valsartanamide release nitrogen monoxide sequentially to prevent nitrate tolerance and oxidative stress.

A water-based ink set stabilizes color performance against light and heat by using a cationic polymer that interacts with the recording medium.

Electroactive compounds with crosslinkable groups enhance hole mobility and device stability.

Immobilizing copper nanoparticles on activated charcoal prevents cell toxicity and biomolecule degradation during automated labeling.

A Suzuki cross-coupling process uses boron esterification reagents to synthesize organic compounds.

Dual N-benzylbenzamide inhibitors address polypharmacy complexity by merging sEH suppression with PPARγ activation for metabolic syndrome treatment.

N-(2-amino-phenyl)amide compounds inhibit histone deacetylase enzymes to modulate chromatin structure.

Adding a polymeric structure improver at 25°C adjusts grease consistency and water resistance, reducing storage costs from separate batch inventories.

Fused heteroaryl compounds target abnormal late sodium current to treat neurological disorders without affecting normal channel function.

A one-pot synthesis process converts dimethoxyacetophenone and dimethoxybenzaldehyde directly into high-purity morin flavonol derivatives.

Asymmetric cyanine compounds minimize background interference and maintain detection accuracy across temperature changes.

Thermal denaturation screening identifies compounds that inhibit HSF1 activity, addressing the lack of effective cancer therapies.

Substituted indane derivatives act as selective HIF-2α inhibitors.

Ion exchange resins remove ammonium sulfate and bisulfate from methionine hydroxy analogs, reducing viscosity below 200 mPa·s at 10°C for easier transport.

Specific onium salt compounds control acid diffusion in ArF immersion lithography resists, reducing line width roughness and improving depth of focus.

N-acyl amino acid compounds inhibit alpha v beta 1 integrin to address limited long-term survival in fibrotic disease treatment.

Pyrimidine compounds act as dual inhibitors targeting EGFR and HER2 receptors, addressing low kinase inhibitor potency in lung cancer therapy.

Structural modifications to inhibitor molecules optimize metabolic stability and oral absorption while maintaining potent neprilysin inhibition.

Inorganic late transition metal salts replace air-sensitive complexes to convert morphinan allyl alcohols into high-purity hydromorphone in a single step.

Fused triphenylene hosts prevent energy quenching and balance charge transport for stable red, green, and blue OLED emitters.

Modular tricyclic heterocyclic compounds inhibit PI3K-p110δ to address limited therapeutic options for cancer and inflammatory diseases.

An organic electroluminescent element uses thermally activated delayed fluorescence compounds to emit light.

Combining donor units with phthalimide acceptors achieves short exciton lifetimes and high quantum yields for efficient blue OLED emitters.

Monoclinic tiotropium bromide crystals maintain stability at high temperatures, resolving batch inconsistency in manufacturing.

Specific compounds inhibit glutaminyl cyclase to reduce cytotoxic peptides, addressing the lack of effective treatments for Alzheimer's disease.

Succinate ester coalescing agents reduce minimum film forming temperature to enable latex particle adhesion in aqueous coatings.

Cyclic carbonate regulators in sulfonium salt resists control acid diffusion to reduce line edge roughness and pattern instability.

A polymerizable monomer with specific aryl groups forms a homogeneous hole-transporting layer via coating.

Aromatic guanidine compounds inhibit mitochondrial oxidative phosphorylation to reprogram cellular metabolism and suppress cancer cell growth.

A monoamine compound with a dibenzothiophene skeleton bonded via a p-phenylene linking group improves electron and hole transport in organic electroluminescent devices.

A modular extraction system isolates cannabinoids and terpenes from plant biomass using solvent dissolution, activated carbon adsorption, and ion exchange columns.

Compounds with tailored heterocyclic cores selectively inhibit O-GlcNAcase, avoiding off-target effects on lysosomal beta-hexosaminidases.

A process converts compound of formula X to lapatinib using thionyl chloride and reductive amination.

Bicyclic heteroaryl amine compounds inhibit PI3Kδ activity with high isoform specificity, resolving adverse effects on non-target isoforms.

A photosensitive material switches between open and ring structures based on light intensity to alter operational modes in photodetectors.

Fluorinated salt cation in resist composition modifies acid generation kinetics to reduce line edge roughness.

UV irradiation degrades colored impurities in discolored ionic liquids, restoring high purity without complex mechanical purification systems.

An indole-based radiopharmaceutical compound provides consistent binding to translocator protein targets.

Isocoumarin derivatives block MIF tautomerase activity to reduce TNF-alpha production and tumor growth in cancers with high MIF expression.

A continuous reactor contacts polycaprolactam waste with superheated steam from a water-hydrocarbon mixture to yield caprolactam.

Selective TLR8 inhibitors bind an allosteric pocket to suppress proinflammatory cytokine production without off-target toxicity.

Modifying the curcumin scaffold with polar groups enhances water solubility while maintaining potent anti-cancer activity.